Cargando…

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?

Detalles Bibliográficos
Autores principales:	Meier, Juris J., Nauck, Michael A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857890/ https://www.ncbi.nlm.nih.gov/pubmed/20427697 http://dx.doi.org/10.2337/db09-1899

Ejemplares similares

Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
por: Meier, Juris J., et al.
Publicado: (2013)

Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
por: Drucker, Daniel J.
Publicado: (2013)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective
por: Garber, Alan J.
Publicado: (2011)

Incretin-Based Therapies: Viewpoints on the way to consensus
por: Nauck, Michael. A., et al.
Publicado: (2009)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2008)

From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes
por: Eizirik, Decio L., et al.
Publicado: (2021)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

How Does Type 1 Diabetes Develop?: The Notion of Homicide or β-Cell Suicide Revisited
por: Atkinson, Mark A., et al.
Publicado: (2011)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Bariatric Surgery: It’s Not Just Incretins!
por: Ferraz-Bannitz, Rafael, et al.
Publicado: (2021)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Air Pollution and Type 2 Diabetes: Mechanistic Insights
por: Rajagopalan, Sanjay, et al.
Publicado: (2012)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention
por: Charles, M. Arthur, et al.
Publicado: (2021)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
por: Purcell, Anthony W., et al.
Publicado: (2019)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
por: Bonner-Weir, Susan, et al.
Publicado: (2008)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
por: Laspe, Insa, et al.
Publicado: (2023)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v976enmsik603geqbo6dhuq4r7